Skip to content
value.today
MedTech Acquisition Corp logo

MedTech Acquisition Corp

MedTech Acquisition Corp is listed today as TriSalus Life Sciences, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of MedTech Acquisition Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2025$22 MPrivate placement after listing$10 to $50 million

MedTech Acquisition Corp: Private sale, May 2025

Investors in this round

24 investors had bought by the notice of May 8, 2025: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for MedTech Acquisition Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian F. Cox · Executive Officer
  • James Young · Executive Officer
  • Jennifer J. Stevens · Executive Officer
  • Jodi J. Devlin · Executive Officer
  • Mary Szela · Executive Officer, Director
  • Richard J. Marshak · Executive Officer
  • Andrew F. von Eschenbach · Director
  • Arjun F. Desai · Director
  • David J. Matlin · Director
  • Gary F. Gordon · Director
  • Kerry F. Hicks · Director
  • Mats J. Wahlstrom · Director
  • Sean Murphy · Director
  • William F. Valle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Young, Chief Financial Officer. Source: SEC Form D, newest notice filed May 8, 2025. Read the notice at the SEC.

equitySEC
Jun 2023$18 MPrivate placement after listing$10 to $50 million

MedTech Acquisition Corp: Private sale, Jun 2023

Investors in this round

17 investors had bought by the notice of Jun 22, 2023: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for MedTech Acquisition Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$18 M of $50 M offered; $32 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$3,319,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher C. Dewey · Executive Officer, Director · Chief Executive Officer
  • David J. Matlin · Executive Officer, Director · Chief Financial Officer
  • Robert H. Weiss · Executive Officer · Chief Administrative Officer and Secretary
  • David L. Treadwell · Director
  • Karim Karti · Director · Chairman
  • Manuel H. Aguero · Director
  • Martin H. Roche · Director
  • Thierry H. Thaure · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ceros Financial Services, Inc. (CRD 37869) · Rockville, MarylandSold in all US states

Remarks in the notice

  • On a merger: “The closing of the sale of the offered securities described herein is contingent upon the completion of a merger transaction involving the offeror.”

Signed by Christopher C. Dewey, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 22, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • MedTech Acquisition Corp chose not to state its revenue in its newest notice of a funding round (May 2025).

    SEC Form D · May 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · May 2025

That is all the official record says: MedTech Acquisition Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of MedTech Acquisition Corp are on record.

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in MedTech Acquisition Corp
InvestorKindAmountRoundRoleSource
Frankenius Equity ABOthernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2023)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding TriSalus Life Sciences, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by MedTech Acquisition Corp
NameRoleNamed in
Brian F. CoxExecutive officerMay 2025
James YoungExecutive officerMay 2025
Jennifer J. StevensExecutive officerMay 2025
Jodi J. DevlinExecutive officerMay 2025
Mary SzelaExecutive officerMay 2025
Richard J. MarshakExecutive officerMay 2025
Christopher C. DeweyChief Executive OfficerJun 2023
David J. MatlinChief Financial OfficerJun 2023
Robert H. WeissChief Administrative Officer and SecretaryJun 2023
Andrew F. von EschenbachDirectorMay 2025
Arjun F. DesaiDirectorMay 2025
David J. MatlinDirectorMay 2025
Gary F. GordonDirectorMay 2025
Kerry F. HicksDirectorMay 2025
Mary SzelaDirectorMay 2025
Mats J. WahlstromDirectorMay 2025
Sean MurphyDirectorMay 2025
William F. ValleDirectorMay 2025
Christopher C. DeweyChief Executive OfficerJun 2023
David L. TreadwellDirectorJun 2023
Karim KartiChairmanJun 2023
Manuel H. AgueroDirectorJun 2023
Martin H. RocheDirectorJun 2023
Thierry H. ThaureDirectorJun 2023

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.